Year archive

SYNLAB AG — 2022 filings

All 34 regulatory filings released by SYNLAB AG (SYAB) in 2022, sourced directly from the official regulator.

34 Filings

2022 Period

2022 filings (34)

Filing	Released	Lang
Q3 statement / Q3 financial report 2022 Interim / Quarterly Report 9M 2022	2022-11-22	English
SYNLAB AG: SYNLAB reports strong underlying performance in 9M 2022, confirms 2022 guidance and releases 2023 guidance Earnings Release 9M 2022	2022-11-10	English
SYNLAB AG: SYNLAB and Microba reinforce their combined expertise and expand strategic agreement on advanced gut microbiome test myBIOME Regulatory Filings	2022-10-27	English
Korrektur der Veroffentlichung vom 22.09.2022, 17:32 Uhr CET/CEST - SYNLAB AG: Veroffentlichung einer Kapitalmarktinformation Transaction in Own Shares	2022-09-22	German
Release of a capital market information Transaction in Own Shares	2022-09-22	English
SYNLAB reports solid H1 2022 results and raises 2022 revenue guidance Earnings Release H1 2022	2022-08-11	English
Half-yearly financial report 2022 Interim / Quarterly Report H2 2022	2022-08-11	German
Report Publication Announcement 2022 Report Publication Announcement	2022-07-29	English
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021 Annual Report (ESEF) FY 2021	2022-05-20	German
Q1 statement / Q1 financial report 2022 Interim / Quarterly Report Q1 2022	2022-05-19	English
SYNLAB reports a strong start to the fiscal year 2022 Earnings Release Q1 2022	2022-05-12	English
SYNLAB AG: SYNLAB Medical Congress: making healthcare future-proof with advanced diagnostics Regulatory Filings	2022-05-10	English
DGAP-DD: SYNLAB AG english Director's Dealing	2022-05-09	English
Disclosure on share buy-back according to Article 2 (1) of the Delegated Regulation (EU) No. 2016/1052 and Article 5 (1) Regulation (EU) No 2014/596 (Market Abuse Regulation) Share Issue/Capital Change	2022-05-09	English
DGAP-DD: SYNLAB AG english Director's Dealing	2022-04-29	English
DGAP-DD: SYNLAB AG english Director's Dealing	2022-04-29	English
DGAP-DD: SYNLAB AG english Director's Dealing	2022-04-29	English
DGAP-DD: SYNLAB AG english Director's Dealing	2022-04-29	English
DGAP-DD: SYNLAB AG english Director's Dealing	2022-04-29	English
DGAP-DD: SYNLAB AG english Director's Dealing	2022-04-29	English
DGAP-DD: SYNLAB AG english Director's Dealing	2022-04-29	English
DGAP-DD: SYNLAB AG english Director's Dealing	2022-04-29	English
DGAP-DD: SYNLAB AG english Director's Dealing	2022-04-29	English
ESG Report 2021: SYNLAB defines high-impact areas to drive its ambitious environmental, social and governance agenda Environmental & Social Information	2022-04-29	English
Annual financial report 2021 Annual Report	2022-04-14	English
SYNLAB AG: Korrektur: Bekanntmachung der Einberufung zur Hauptversammlung am 16.05.2022 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG AGM Information	2022-04-08	German
SYNLAB AG: Bekanntmachung der Einberufung zur Hauptversammlung am 16.05.2022 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG AGM Information	2022-04-06	German
SYNLAB AG: SYNLAB partners with OncoDNA to provide comprehensive biomarker testing for cancer therapy selection in Germany Regulatory Filings	2022-03-29	English
SYNLAB AG approves share buy-back to service participation programs Transaction in Own Shares	2022-03-24	English
SYNLAB AG: SYNLAB achieves record results in 2021 and exceeds all targets set at the IPO Earnings Release FY 2021	2022-03-16	English
SYNLAB AG: SYNLAB joins the United Nations Global Compact initiative Environmental & Social Information	2022-03-11	English
Report Publication Announcement 2022 Report Publication Announcement	2022-03-01	English
Hinweis auf Jahresfinanzbericht vom 01.01.2021 bis zum 31.12.2021 Report Publication Announcement	2022-03-01	German
SYNLAB acquires Sistemas Genomicos of the Ascires Group in Spain, further strengthening its European leadership in genetics M&A Activity	2022-01-07	English